Cancers · 2022 · 32 citations · 49 references
MedicineOncologyPharmacologyMolecular OncologyPediatric OncologyPrecision OncologyMolecular Tumor ProfilingOncology PharmacologyPediatric Cancer BiologyPersonalized Cancer TherapyTargeted Cancer TherapyFunctional AssaysFunctional ScreeningFunctional Screening AssaysIndividualized Drug TherapyPersonalized Cancer TreatmentRelapsed Childhood CancerSpheroid Culture ModelsTumor Profiling
The survival rate among children with relapsed tumors remains poor, due to tumor heterogeneity, lack of directly actionable tumor drivers and multidrug resistance. Novel personalized medicine approaches tailored to each tumor are urgently needed to improve cancer treatment. Current pediatric precision oncology platforms, such as the INFORM (INdividualized Therapy FOr Relapsed Malignancies in Childhood) study, reveal that molecular profiling of tumor tissue identifies targets associated with clinical benefit in a subgroup of patients only and should be complemented with functional drug testing. In such an approach, patient-derived tumor cells are exposed to a library of approved oncological drugs in a physiological setting, e.g., in the form of animal avatars injected with patient tumor cells. We used molecularly fully characterized tumor samples from the INFORM study to compare drug screen results of individual patient-derived cell models in functional assays: (i) patient-derived spheroid cultures within a few days after tumor dissociation; (ii) tumor cells reisolated from the corresponding mouse PDX; (iii) corresponding long-term organoid-like cultures and (iv) drug evaluation with the corresponding zebrafish PDX (zPDX) model. Each model had its advantage and complemented the others for drug hit and drug combination selection. Our results provide evidence that in vivo zPDX drug screening is a promising add-on to current functional drug screening in precision medicine platforms.
49
DNA methylation-based classification of central nervous system tumours
David Capper, David Jones, Martin Sill et al. · Nature · 2018 · 3.1K citations · Full text
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Isabella Versteege, Nicolas Sévenet, Julian Lange et al. · Nature · 1998 · 1.5K citations
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
Trista E. North, Wolfram Goessling, Carl R. Walkley et al. · Nature · 2007 · 1.1K citations · Full text
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Jaclyn A. Biegel, Junying Zhou, Lucy B. Rorke et al. · PubMed · 1999 · 844 citations